Biotech

Anatara Lifesciences Ltd (ASX:ANR) Market Update COVID-19

🕔4/7/2020 10:06:03 AM

Anatara Lifesciences Ltd (ASX:ANR) provides an update on the impact to the Company of the COVID-19 pandemic.

Read Full Article

Regeneus Ltd (ASX:RGS) to be granted new key Progenza patent in U.S.

🕔3/23/2020 9:42:44 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced that the U.S Patent and Trademark Office (USPTO) has issued a notice of allowance for issuance of a new key patent for the Company's lead stem cell platform technology, Progenza, in the U.S.

Read Full Article

Regeneus Ltd (ASX:RGS) Receives A$1.6M Milestone Payment from Kyocera

🕔3/20/2020 9:49:10 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, Today received a non-refundable milestone payment of 100,000,000 JPY (approx. A$1.6M) from Kyocera Corporation (TYO:6971) as set out in the non-binding Memorandum of Understanding (MOU) signed on 2 March 2020.

Read Full Article

Regeneus Ltd (ASX:RGS) Signs MOU with Kyocera Corporation

🕔3/2/2020 10:23:45 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced it has signed a non-binding MOU with Kyocera Corporation (Kyocera, TYO:6971).

Read Full Article

Regeneus Ltd (ASX:RGS) Half-Year Results & Business Update

🕔2/28/2020 4:16:21 PM

Regeneus Ltd (ASX:RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, today released its Half-Year Financial Results and Appendix 4D for the period ended 31 December 2019 (H1 FY20).

Read Full Article

Regeneus Ltd (ASX:RGS) Directors Provide $4m Loan Facility

🕔2/28/2020 4:09:21 PM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced its Board of Directors has put in place loan facilities totalling $4 million to extend the Company's funding runway to support negotiations to license and commercialise Progenza for knee osteoarthritis (Progenza OA) in Japan.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Half Yearly Report and Accounts

🕔2/25/2020 12:19:48 PM

Anatara Lifesciences Ltd (ASX:ANR) present their report on the consolidated entity consisting of Anatara Lifesciences Ltd and the entities it controlled at the end of, or during, the half-year ended 31 December 2019.

Read Full Article